These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7537218)

  • 1. Trypanosoma cruzi: transfer of protection by lymph node cells obtained from mice immunized with exoantigens of pI 4.5.
    Gruppi A; Cerban F; Pistoresi-Palencia MC; Vottero-Cima E
    Exp Parasitol; 1995 May; 80(3):382-9. PubMed ID: 7537218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi: involvement of IgG isotypes in the parasitemia control of mice immunized with parasite exoantigens of isoelectric point 4.5.
    Cerban F; Gruppi A; Vottero-Cima E
    Exp Parasitol; 1992 Aug; 75(1):137-45. PubMed ID: 1639159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi: immune response in mice immunized with parasite antigens.
    Rottenberg ME; Cardoni RL; deTitto EH; Moreno M; Segura EL
    Exp Parasitol; 1988 Feb; 65(1):101-8. PubMed ID: 2892694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi exoantigens: can those recognized by sera from chagasic patients trigger a protective immune response in mice?
    Gruppi A; Pistoresi-Palencia MC; Cerban F; Vottero-Cima E
    Res Immunol; 1991; 142(9):821-8. PubMed ID: 1796212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-associated changes in lymphoid and antigen-presenting cell functions in mice immunized with Trypanosoma cruzi antigens.
    Maletto BA; Gruppi A; Moron G; Pistoresi-Palencia MC
    Mech Ageing Dev; 1996 Jul; 88(1-2):39-47. PubMed ID: 8803920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
    Introini MV; Basso B; Moretti E
    Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity.
    Taibi A; Plumas-Marty B; Guevara-Espinoza A; Schöneck R; Pessoa H; Loyens M; Piras R; Aguirre T; Gras-Masse H; Bossus M
    J Immunol; 1993 Sep; 151(5):2676-89. PubMed ID: 7689612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection.
    Curotto de Lafaille MA; Barbosa de Oliveira LC; Lima GC; Abrahamsohn IA
    Exp Parasitol; 1990 Feb; 70(2):164-74. PubMed ID: 2105229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytomonas serpens, a tomato parasite, shares antigens with Trypanosoma cruzi that are recognized by human sera and induce protective immunity in mice.
    Breganó JW; Picão RC; Graça VK; Menolli RA; Itow Jankevicius S; Pinge Filho P; Jankevicius JV
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):257-64. PubMed ID: 14642311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease.
    Taibi A; Espinoza AG; Ouaissi A
    Immunol Lett; 1995 Dec; 48(3):193-200. PubMed ID: 8867851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
    Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
    Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.
    Costa F; Franchin G; Pereira-Chioccola VL; Ribeirão M; Schenkman S; Rodrigues MM
    Vaccine; 1998 May; 16(8):768-74. PubMed ID: 9627933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and pathological responses in BALB/c mice induced by genetic administration of Tc 13 Tul antigen of Trypanosoma cruzi.
    García GA; Arnaiz MR; Laucella SA; Esteva MI; Ainciart N; Riarte A; Garavaglia PA; Fichera LE; Ruiz AM
    Parasitology; 2006 Jun; 132(Pt 6):855-66. PubMed ID: 16478565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.